March 17, 2014
Seattle’s King5 TV highlights recent SPI clinical trial
to prevent and treat hearing loss…Read
February 18, 2014
Sound Pharma submits scientific paper for presentation
on positive SPI-1005 Phase 2 clinical trial...Read
November 5, 2013
SPI completes mid-stage Ph-II clinical trial in Noise Induced
September 15, 2013
Noise at sporting events can damage hearing...Read
Seattle Times Article...
March 7, 2013
ABC news highlights hearing loss as a growing trend in society and the impact of using earbuds at high volume. Watch this informative video with lead reporter Diane Sawyer...
December 5, 2012
Sound Pharmaceuticals and the University of Florida begin
enrollment on a Phase II study with SPI-1005 to prevent and treat
noise induced hearing loss…Read
November 28, 2012
Nobel Prize Winner Bruce Beutler joins Sound Pharmaceuticals
Scientific Advisory Board...Read
November 13, 2012
SPI granted patent for prevention and treatment of side
effects of chemotherapy...Read
May 4, 2012
SPI in Nature Medicine’s “Sound Medicine”
February 9, 2012
Seattle’s King5TV shows story on noise induced hearing loss
More and Watch Video...
February 2, 2012
Tampa FoxTV runs story on SPI-1005 to prevent hearing loss…Read
More and Watch Video...
November 29, 2011
UF researchers to evaluate SPI-1005 in iPod clinical trial…Read
September 6, 2011
Bioworld Insight coverage on hearing loss R&D... Read
More (Pg. 2)...
June 6, 2011
Sound Pharma announces a new otoprotection clinical trial involving
personal music players… Read
February 24, 2011
UCLA and Sound Pharmaceuticals identify a key hearing regeneration
protein in the human inner ear... Read
November 1, 2010
Sound Pharma receives grants from the IRS under the Qualifying
Therapeutic Discovery Project program created by the Patient Protection
and Affordable Care Act of 2010... Read
September 15, 2010
Sound Pharma to receive $3M in DoD funding to further develop
our hearing regeneration program through Sen. Patty Murray’s recommendation
and support… Read
June 8, 2010
Sound Pharma’s otoprotection and regeneration work
were presented at the Office of Naval Research Conference on Noise
Induced Hearing Loss in San Diego, CA. ONR commissioned a video
demonstrating some of its externally funded research efforts in
August 19, 2009
SPI receives Office of Naval Research award for hearing loss research and development. Read
November 12, 2008
SPI awarded best presentation at the 16th Annual AMSCON/AMSUS
meeting for it's clinical otoprotection work. Read
more about AMSUS...
October 30, 2008
SPI invited to be a speaker at GTCBio's CNS Diseases Partnering
and Deal-Making Summit.
See Current Conferences by GTCBio...
August 7, 2008
FDA Allows Phase 2 Study for Sound Pharmaceuticals' Novel
Drug to Prevent Chemotherapy Induced Hearing Loss.
July 23, 2008
Sound Pharmaceuticals Files Second IND with the FDA for
the Prevention of Chemotherapy Induced Hearing Loss in Advanced
Stage Cancer. Read
July 21, 2008
Sound Pharmaceuticals Receives Additional DoD Funding for Its Hearing
Regeneration Product. Read More...
March 25, 2008
VentureWire Lifesciences story covers Sound Pharma's start of Ph-II
clinical trials of SPI-1005 to prevent and treat noise induced hearing
loss. Read more...
August 31, 2007
Neurotech Insights newsletter focuses on Hearing Loss and
current R & D efforts of SPI (pg.14)...
July 1, 2007
LA Times article on Otoprotection. Read
January 4, 2007
Sound Pharmaceuticals Announces the Successful Completion
of its Phase I Clinical Trial for SPI-1005.
October 13, 2006
Sound Pharmaceuticals supports the formation of the Neurotechnology
Industry Organization (NIO) as a founding member. Read
July 7, 2006
USPTO issues Notice of Allowance for Novel Patent on Hair Cell Regeneration
in the Inner Ear.
June 21, 2006
Sound Pharmaceuticals interviewed by MIT Technology Review. Read
June 12, 2006
New Drug for Hearing Loss Enters Clinical Testing.
March 21, 2006
Sound Pharmaceuticals presents at Invest Northwest Life